SCHEMBL30953440

SCHEMBL30953440

CC1CCC([C@H](NC(=O)OC(C)(C)C)C(=O)Nc2cc(O)ccn2)CC1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 7/20 0.51
▸ MMP1 P03956 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ TGFBR1 P36897 1/20 0.35
▸ ATR Q13535 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ MMP9 P14780 1/20 0.33
▸ ADAM17 P78536 1/20 0.33
▸ MAP1LC3B Q9GZQ8 1/20 0.33
▸ MAP1LC3A Q9H492 1/20 0.33
▸ ACACB O00763 1/20 0.32
▸ ACACA Q13085 1/20 0.32
▸ TYK2 P29597 1/20 0.32
▸ PYGL P06737 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30953402 0.89 AAK1 (0.60) AAK1MMP1LMNARAB9A
SCHEMBL27393615 0.87 AAK1 (0.48) AAK1MMP1LMNARAB9AKDM4E
SCHEMBL30953269 0.87 AAK1 (0.48) AAK1MMP1LMNARAB9ATGFBR1
SCHEMBL30953221 0.87 AAK1 (0.48) AAK1MMP1LMNARAB9AKDM4E
SCHEMBL27393638 0.87 AAK1 (0.48) AAK1MMP1LMNARAB9ATGFBR1
SCHEMBL30953339 0.86 AAK1 (0.50) AAK1MMP1LMNARAB9AKDM4E
SCHEMBL30953274 0.86 AAK1 (0.48) AAK1MMP1LMNARAB9ATGFBR1
SCHEMBL30953381 0.85 AAK1 (0.46) AAK1MMP1LMNARAB9ATGFBR1
SCHEMBL30953316 0.84 AAK1 (0.44) AAK1MMP1LMNARAB9AMMP2
SCHEMBL30953276 0.84 AAK1 (0.44) AAK1MMP1LMNARAB9AACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback